Astrazeneca Pharma India informs about updates

20 Jan 2024 Evaluate
Astrazeneca Pharma India has informed that AstraZeneca Pharma India has received permission to Import pharmaceutical formulations of new drug for sale or for distribution in Form CT-20 from Central Drugs Standard Control Organisation for Andexanet alfa powder for solution for infusion 200mg (Andexxa).

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8606.35 112.45 (1.32%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...